Effectiveness and Safety of Sofosbuvir-Based Regimens for Chronic HCV Genotype 3 Infection: Results of the HCV-TARGET Study

Background. Sofosbuvir (SOF) is active against all hepatitis C virus (HCV) genotypes, and SOF-based therapies lead to high rates of sustained virologic response (SVR). However, genotype 3 (GT3) HCV remains a challenge with lower SVR rates reported, particularly in patients with cirrhosis. This study...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: Feld, Jordan J., Maan, Raoel, Zeuzem, Stefan, Kuo, Alexander, Nelson, David R., Di Bisceglie, Adrian M., Manns, Michael P., Sherman, Ken, Frazier, Lynn M., Sterling, Richard, Mailliard, Mark, Schmidt, Monica, Akushevich, Lucy, Vainorius, Monika, Fried, Michael W.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2016
Assuntos:
Articles and Commentaries
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4996139/
https://ncbi.nlm.nih.gov/pubmed/27325691
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciw387
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados